CELLINK announced a distribution partnership with Kugelmeiers Ltd. to bring to market CELLINK Spheroid Kits, which package Kugelmeiers Sphericalplate 5D for forming highly standardized spheroids with CELLINK’s vast portfolio of bioinks. The Spheroid Kits will be distributed globally, except in Japan and Switzerland, through CELLINK’s existing marketing and distribution network.
Culturing cell spheroids is an important emerging field for cell biologists that can be used in scientific, diagnostic and therapeutic applications. When coupled with 3D bioprinting, the enhanced biological functionality and accuracy of spheroids can be used like “building blocks” for tissue engineering. Kugelmeiers and CELLINK are proud of this partnership that makes CELLINK Spheroid Kits available to help researchers optimize workflows for an automated solution to spheroid development.
A future for our children and grandchildren, whose medical care is governed and guided by health and not disease: Safe cell treatments and regenerative therapies that heal and save lives; humane and accessible to everyone. We have dedicated ourselves to the regenerative medicine – ethical, responsible, visionary and passionate!
Kugelmeiers contributes to and provides accessibility to regenerative medicine, believing it to be a potential for future medical therapies that everyone should have access to. We developed as a result of 18 years of research and dedication in the ﬁeld of transplant surgery, cell therapy and developmental biology, a technology and ecosystems allowing us to make an impact on islet, liver and many other cell therapies that rely on 3D spheroids that need a medical quality platform.
Our company was founded in 2015 as a spin-off from the University of Zurich in Switzerland.